| Susan T Voss, NP | |
|
211 S 3rd St, Louisiana, MO 63353-2000 | |
| (573) 754-5555 | |
| (573) 754-4077 |
| Full Name | Susan T Voss |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 26 Years |
| Location | 211 S 3rd St, Louisiana, Missouri |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1558379735 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | RN104354 (Missouri) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Riverside Dermatology And Spa Llc | 7214282227 | 4 |
News Archive
Physicians who specialize in a devastating and aggressive immune disorder called hemophagocytic lymphohistiocytosis report in a new study that extra care should be taken to ensure an HLH diagnosis doesn't obscure possible underlying cancers.
ConjuChem Biotechnologies Inc. ("ConjuChem") (TSX:CJB) today announced the completion of the transaction providing $5 million in new, non-dilutive capital to the Company. The Superior Court of Québec has approved the previously announced plan of arrangement (the "Arrangement") under section 192 of the Canada Business Corporations Act (the "CBCA") involving ConjuChem and Colabor Income Fund ("Colabor"), among others, all as fully described in ConjuChem's management information circular dated July 17, 2009.
A novel drug developed by Gilead Sciences and tested in an animal model at the Texas Biomedical Research Institute in San Antonio suppresses hepatitis B virus infection by stimulating the immune system and inducing loss of infected cells.
St. Jude Children's Research Hospital researchers have evidence that common genetic variations can help to identify pediatric cancer survivors who are at increased risk for developing breast cancer while relatively young. The findings appear today in the journal Clinical Cancer Research.
› Verified 8 days ago
| Entity Name | Riverside Dermatology & Spa Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699262329 PECOS PAC ID: 7214282227 Enrollment ID: O20180615000066 |
News Archive
Physicians who specialize in a devastating and aggressive immune disorder called hemophagocytic lymphohistiocytosis report in a new study that extra care should be taken to ensure an HLH diagnosis doesn't obscure possible underlying cancers.
ConjuChem Biotechnologies Inc. ("ConjuChem") (TSX:CJB) today announced the completion of the transaction providing $5 million in new, non-dilutive capital to the Company. The Superior Court of Québec has approved the previously announced plan of arrangement (the "Arrangement") under section 192 of the Canada Business Corporations Act (the "CBCA") involving ConjuChem and Colabor Income Fund ("Colabor"), among others, all as fully described in ConjuChem's management information circular dated July 17, 2009.
A novel drug developed by Gilead Sciences and tested in an animal model at the Texas Biomedical Research Institute in San Antonio suppresses hepatitis B virus infection by stimulating the immune system and inducing loss of infected cells.
St. Jude Children's Research Hospital researchers have evidence that common genetic variations can help to identify pediatric cancer survivors who are at increased risk for developing breast cancer while relatively young. The findings appear today in the journal Clinical Cancer Research.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Susan T Voss, NP 163 Medical Dr, Hannibal, MO 63401-6884 Ph: (573) 719-1818 | Susan T Voss, NP 211 S 3rd St, Louisiana, MO 63353-2000 Ph: (573) 754-5555 |
News Archive
Physicians who specialize in a devastating and aggressive immune disorder called hemophagocytic lymphohistiocytosis report in a new study that extra care should be taken to ensure an HLH diagnosis doesn't obscure possible underlying cancers.
ConjuChem Biotechnologies Inc. ("ConjuChem") (TSX:CJB) today announced the completion of the transaction providing $5 million in new, non-dilutive capital to the Company. The Superior Court of Québec has approved the previously announced plan of arrangement (the "Arrangement") under section 192 of the Canada Business Corporations Act (the "CBCA") involving ConjuChem and Colabor Income Fund ("Colabor"), among others, all as fully described in ConjuChem's management information circular dated July 17, 2009.
A novel drug developed by Gilead Sciences and tested in an animal model at the Texas Biomedical Research Institute in San Antonio suppresses hepatitis B virus infection by stimulating the immune system and inducing loss of infected cells.
St. Jude Children's Research Hospital researchers have evidence that common genetic variations can help to identify pediatric cancer survivors who are at increased risk for developing breast cancer while relatively young. The findings appear today in the journal Clinical Cancer Research.
› Verified 8 days ago
Dr. Casey Amanda Jennings, D. O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2305 Georgia St, Louisiana, MO 63353 Phone: 573-754-4584 Fax: 573-754-5280 | |
Dr. Stephen Francis Justice, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2305 Georgia, Louisiana, MO 63353 Phone: 573-754-4584 Fax: 573-754-5280 | |
Phillip W Pitney, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 211 S 3rd St, Louisiana, MO 63353 Phone: 573-754-5555 Fax: 573-754-4077 | |
Howard Gilbert Greene, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2305 Georgia St, Louisiana, MO 63353 Phone: 573-754-4584 Fax: 573-754-5280 | |
Jan F Onik, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 211 S 3rd St, Louisiana, MO 63353 Phone: 573-754-5555 Fax: 573-754-4077 | |
Andrew Hyatt, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 2305 Georgia St, Louisiana, MO 63353 Phone: 573-754-4584 |